CN110156789B - Synthetic method of azacyclo-quinazoline compound - Google Patents

Synthetic method of azacyclo-quinazoline compound Download PDF

Info

Publication number
CN110156789B
CN110156789B CN201910425623.6A CN201910425623A CN110156789B CN 110156789 B CN110156789 B CN 110156789B CN 201910425623 A CN201910425623 A CN 201910425623A CN 110156789 B CN110156789 B CN 110156789B
Authority
CN
China
Prior art keywords
azacyclo
quinazoline
quinazoline compound
aromatic amine
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910425623.6A
Other languages
Chinese (zh)
Other versions
CN110156789A (en
Inventor
乐长高
卢粤
谢宗波
姜国芳
朱潇
胡智宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
East China Institute of Technology
Original Assignee
East China Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by East China Institute of Technology filed Critical East China Institute of Technology
Priority to CN201910425623.6A priority Critical patent/CN110156789B/en
Publication of CN110156789A publication Critical patent/CN110156789A/en
Application granted granted Critical
Publication of CN110156789B publication Critical patent/CN110156789B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses a synthetic method of an azacyclo-quinazoline compound, which comprises the following steps: placing benzaldehyde with a structure shown in a formula A and aromatic amine with a structure shown in a formula B in a methanol water solution or a methanol solution, wherein the molar ratio of the benzaldehyde to the aromatic amine is more than or equal to 2: 1, stirring at a constant temperature of 55-65 ℃ under the catalytic action of porcine gastric mucosal protease, and reacting to obtain an azacyclo-quinazoline compound with a structure shown in a formula C; wherein R1 and R2 form an azacyclic ring. The method has the advantages of mild reaction conditions, biodegradable catalyst, simple steps, low cost, easy implementation of the whole synthesis path, economy, environmental protection, good yield which reaches 41-95 percent, and popularization and use values.

Description

Synthetic method of azacyclo-quinazoline compound
Technical Field
The invention belongs to the field of organic matter synthesis, and particularly relates to a synthetic method of a nitrogen heterocyclic quinazoline compound.
Background
Quinazoline derivatives are nitrogen-containing heterocyclic compounds with good biological activity, and quinazoline skeletons can also be found in active substances in a plurality of natural products. The quinazoline compound is widely applied to the pharmaceutical and pesticide industries and can be applied to the fields of cancer resistance, malaria resistance, hypertension resistance, mite killing, sterilization and the like. Some quinazoline derivatives have been put on the market or subjected to medical clinical tests, such as the anticancer drug gefitinib and the bactericide propoxymidine. Therefore, the synthesis of quinazoline compounds is receiving continuous attention from scientists.
The traditional method for synthesizing quinazoline compounds usually uses o-aminobenzaldehyde, o-aminobenzoic acid, o-amino-formamide or o-aminobenzonitrile and the like as starting materials to synthesize quinazoline compounds
Figure GDA0002582331160000011
Acids, Lewis acids, transition metals, ionic liquids and the like are synthesized as catalysts, although some green catalysts are reported here, the synthesis methods have some defects compared with green organic synthesis, such as complicated operation process, unrecoverable or degradable catalysts, overhigh cost, small applicable range of substrates and the like. Therefore, the development of an economic and environment-friendly green preparation method with wider application range has positive significance.
Based on the characteristics of high efficiency, low toxicity, mildness, selectivity and the like of biocatalysis, the method has profound influence on the aspects of industry, agriculture, medical treatment, new drug research and development and the like, and is one of the important trends of green chemistry and green chemical engineering development. The enzyme is a commonly used bioactive catalyst, plays an important role in the field of organic synthesis, and has the advantages of high efficiency, specificity, degradability, no pollution, environmental friendliness, economy and the like.
The technical process for synthesizing the [1,2-a ] quinazoline compound by the existing process is complex, has high energy consumption and causes great pollution to the environment, so that the development of the method for synthesizing the [1,2-a ] quinazoline compound by enzyme catalysis has important significance.
Disclosure of Invention
The invention aims to provide a synthetic method of a nitrogen heterocyclic quinazoline compound, which solves the problem of great environmental pollution in the prior art, has mild reaction conditions, biodegradable catalyst, simple steps, low cost, easy implementation of the whole synthetic route, economy, environmental protection and popularization and use values.
In order to achieve the above object, the present invention provides a method for synthesizing an azacyclo-quinazoline compound, the method comprising:
Figure GDA0002582331160000021
placing benzaldehyde with a structure shown as a formula A and aromatic amine with a structure shown as a formula B in a methanol water solution or a methanol solution, wherein the molar ratio of the benzaldehyde to the aromatic amine is larger than or equal toEqual to 2: 1, oscillating at 55-65 ℃ under the catalytic action of porcine gastric mucosal protease to react to obtain an azacyclo-quinazoline compound with a structure shown as a formula C; wherein R is1And R2Are connected to form a nitrogen heterocycle.
According to the method, the yield of the azacyclo-quinazoline compound can reach 38% at the temperature of 40 ℃; the yield of the azacyclo-quinazoline compound reaches 51 percent at the temperature of 45 ℃; the yield of the azacyclo-quinazoline compound reaches 61 percent at the temperature of 50 ℃; the yield of the azacyclo-quinazoline compound reaches 71 percent at the temperature of 55 ℃; the yield of the azacyclo-quinazoline compound reaches 75 percent at the temperature of 60 ℃; the yield of the azacyclo-quinazoline compound reaches 74 percent at the temperature of 65 ℃. Therefore, the temperature range is preferably 55-60 ℃ to improve the yield of the azacyclo-quinazoline compound.
According to the method, when the porcine gastric mucosa protease is used as the catalyst, the yield of the azacyclo-quinazoline compound is good, and no product is generated when the catalyst is not added. Therefore, the reaction of the present invention must be catalyzed by porcine gastric mucosal protease to greatly improve the yield.
Preferably, the volume ratio of methanol to water in the methanol aqueous solution is 1: 2-2: 1.
preferably, the rotating speed of the oscillation is 150-250 rpm.
Preferably, the reaction time is not less than 36 h. More preferably, the reaction time is 36-48 h. The yield increased with longer reaction time, but after 48h the yield decreased.
Preferably, the mass molar ratio of the porcine gastric mucosa protease to the aromatic amine is 75mg:1 mmol-150 mg:1 mmol; the volume mol ratio of the methanol water solution to the aromatic amine is 5mL:1 mmol-10 mL:1 mmol.
Preferably, after the reaction is finished, the reaction product is separated and purified by column chromatography.
Preferably, the eluent used for the column chromatography is ethyl acetate-petroleum ether or dichloromethane-n-hexane. More preferably, the eluent is ethyl acetate and petroleum ether in a volume ratio of 1:15, or dichloromethane and n-hexane in a volume ratio of 1: 1.
Preferably, R1And R2Comprises the following steps: -CH2-(CH2)m-CH2-, m is 1 to 6; or
Figure GDA0002582331160000031
n is 0 to 4, and D is a carbocyclic ring or a heterocyclic ring. More specifically, R1And R2The N heterocyclic ring comprises:
Figure GDA0002582331160000032
Figure GDA0002582331160000033
more specifically, the carbocyclic or heterocyclic ring includes carbocyclic or heterocyclic rings of five or more members, such as carbocyclic or heterocyclic rings of five members, six-membered carbocyclic or heterocyclic rings, seven-membered carbocyclic or heterocyclic rings, and eight-membered carbocyclic or heterocyclic rings.
Preferably, D is an aromatic ring, more particularly, it includes a benzene ring, R1And R2The N heterocyclic ring comprises:
Figure GDA0002582331160000034
preferably, the aromatic amine has a structure as shown in formula E or F:
Figure GDA0002582331160000035
wherein R is3And R4Each independently is H, or an electron donating substituent, or an electron withdrawing substituent; g is a carbocyclic or heterocyclic ring, and can be a saturated carbocyclic or heterocyclic ring, and can also be an unsaturated carbocyclic or heterocyclic ring. Wherein the electron donating substituent is an electron donating substituent that does not affect the reaction of the amino group in the aromatic amine with benzaldehyde, and does not comprise: amino and hydroxyl. More specifically, the unsaturated carbocyclic or heterocyclic ring, or the saturated carbocyclic or heterocyclic ring, may be a five-membered ring, a six-membered ring, and the unsaturated carbocyclic ring comprises a benzene ring.
Preferably, the electron-donating substituent is selected from any one of methyl, ethyl, methoxy and ethoxy; the electron-withdrawing substituent is selected from any one of halogen, trifluoromethyl, nitro and cyano.
The synthetic method of the azacyclo-quinazoline compound solves the problem that the existing process has great environmental pollution, and has the following advantages:
the method has the advantages of mild reaction conditions, biodegradable catalyst, simple steps, low cost, easy implementation of the whole synthesis path, economy, environmental protection, good yield which reaches 41-95 percent, and popularization and use values.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A synthetic method of an azacyclo-quinazoline compound comprises the following synthetic route:
Figure GDA0002582331160000041
the method specifically comprises the following steps:
1) in a 10mL stoppered tube, 0.4mmol of 2- (1-pyrrolidinyl) benzaldehyde, 0.2mmol of aniline, 30mg of porcine gastric mucosal protease and 2mL of 50% aqueous methanol solution were added;
2) putting the test tube in the step 1) into a constant-temperature oil bath at 60 ℃, and reacting for 36 hours under magnetic stirring to obtain a crude product;
3) and (3) carrying out column chromatography separation on the crude product obtained in the step 2), wherein ethyl acetate and petroleum ether are adopted as eluent in a volume ratio of 1:10, and drying at 40 ℃ for 3-4 h to prepare the azacyclo-quinazoline compound.
The prepared azacyclo-quinazoline compound is 4-phenyl-1, 2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 75%, and the azacyclo-quinazoline compound is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.32(dd,J=10.6,5.1Hz,2H),7.20-7.11(m,4H),6.97(d,J=7.4Hz,1H),6.65(t,J=7.4Hz,1H),6.54(d,J=8.1Hz,1H),4.64(dd,J=8.3,5.3Hz,1H),4.39(d,J=14.9Hz,1H),4.13-4.11(m,1H),3.46(td,J=8.7,3.0Hz,1H),3.38(dd,J=16.5,8.2Hz,1H),2.08(dd,J=8.6,3.6Hz,1H),1.98(ddd,J=9.9,5.3,2.3Hz,1H),1.95-1.87(m,1H),1.73(ddd,J=16.5,10.1,5.5Hz,1H)。13C NMR(126MHz,CDCl3)150.28,143.47,128.99,127.82,125.97,125.22,124.81,120.84,116.18,111.36,76.72,57.37,47.10,32.00,22.29。
example 2
Figure GDA0002582331160000051
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 1, except that 4-methylaniline is used as aromatic amine, and the prepared azacyclo-quinazoline compound is 4- (p-tolyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 66%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.17-7.05(m,5H),6.95(d,J=7.3Hz,1H),6.63(t,J=7.3Hz,1H),6.52(d,J=8.0Hz,1H),4.60(dd,J=8.3,5.2Hz,1H),4.35(d,J=14.9Hz,1H),4.06(d,J=14.9Hz,1H),3.52-3.29(m,2H),2.32(s,3H),2.04-1.87(m,3H),1.71(ddd,J=11.5,9.9,5.7Hz,1H)。13C NMR(126MHz,CDCl3)147.70,143.42,134.62,129.65,127.81,126.03,125.26,120.84,116.08,111.29,76.93,57.62,47.14,32.09,22.34,20.96。
example 3
Figure GDA0002582331160000052
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 1, except that the aromatic amine is 3-methylaniline, and the prepared azacyclo-quinazoline compound is 4- (m-tolyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 68%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.20(t,J=7.7Hz,1H),7.13(t,J=7.6Hz,1H),7.10-6.88(m,4H),6.64(t,J=7.4Hz,1H),6.53(d,J=8.0Hz,1H),4.61(dd,J=8.3,5.2Hz,1H),4.34(d,J=14.8Hz,1H),4.10(d,J=14.8Hz,1H),3.53-3.33(m,2H),2.34(s,3H),2.11-1.84(m,3H),1.73(tt,J=11.5,8.2Hz,1H)。13C NMR(126MHz,CDCl3)150.26,143.33,138.72,128.75,127.76,125.94,125.85,125.61,121.87,120.83,116.07,111.30,76.69,57.47,47.12,32.10,22.28,21.50。
example 4
Figure GDA0002582331160000061
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 1, except that the aromatic amine is 2-methylaniline, and the prepared azacyclo-quinazoline compound is 4- (o-tolyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 55%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.27-7.19(m,1H),7.15(t,J=7.9Hz,2H),7.08(t,J=7.1Hz,2H),6.94(d,J=7.3Hz,1H),6.64(t,J=7.3Hz,1H),6.58(d,J=8.0Hz,1H),4.74(t,J=14.4Hz,1H),4.14(s,1H),3.89(d,J=15.0Hz,1H),3.52(t,J=7.2Hz,1H),3.37(dd,J=16.2,8.6Hz,1H),2.34(d,J=12.1Hz,3H),2.05-1.81(m,3H),1.51(tt,J=11.6,8.1Hz,1H)。13C NMR(126MHz,CDCl3)146.08,143.76,136.74,130.55,127.56,126.66,125.95,125.06,115.87,111.76,109.69,99.93,76.35,56.67,47.65,32.69,22.54,17.97。
example 5
Figure GDA0002582331160000071
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 1, except that 4-methoxyaniline is adopted as aromatic amine, and the prepared azacyclo-quinazoline compound is 4- (4-methoxyphenyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 50%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.16-7.08(m,3H),6.95(d,J=7.3Hz,1H),6.88-6.82(m,2H),6.63(t,J=7.2Hz,1H),6.52(d,J=8.0Hz,1H),4.57(dd,J=8.3,5.0Hz,1H),4.36(d,J=14.9Hz,1H),4.01(d,J=14.9Hz,1H),3.79(s,3H),3.46(td,J=8.6,2.6Hz,1H),3.36(dd,J=15.9,8.6Hz,1H),2.01–1.82(m,3H),1.69(ddd,J=11.2,8.3,3.6Hz,1H)。13C NMR(126MHz,CDCl3)157.13,143.39,143.09,127.80,126.80,126.07,120.82,116.02,114.18,111.23,77.27,57.63,55.44,47.13,32.01,22.33。
example 6
Figure GDA0002582331160000072
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 1, except that 4-fluoroaniline is used as aromatic amine, and the prepared azacyclo-quinazoline compound is 4- (4-fluorophenyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 60%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.53(d,J=8.5Hz,2H),7.16(d,J=8.4Hz,3H),6.99(d,J=7.3Hz,1H),6.70(t,J=7.4Hz,1H),6.57(d,J=8.0Hz,1H),4.65(dd,J=8.3,5.4Hz,1H),4.42(d,J=15.0Hz,1H),4.21(d,J=15.0Hz,1H),3.48-3.32(m,2H),2.22(tdd,J=7.7,5.5,2.7Hz,1H),2.08-1.87(m,2H),1.74(ddd,J=18.9,12.0,8.6Hz,1H)。13C NMR(126MHz,CDCl3)153.01,143.78,128.07,126.14,126.05,125.86,123.24,120.93,116.99,111.73,75.88,55.69,46.75,31.62,22.01。
example 7
Figure GDA0002582331160000081
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 1, except that 4-chloroaniline is used as aromatic amine, and the prepared azacyclo-quinazoline compound is 4- (4-chlorophenyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 61%, and the product is white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.25(dd,J=9.5,2.7Hz,2H),7.14(t,J=7.7Hz,1H),7.11-7.03(m,2H),6.96(d,J=7.3Hz,1H),6.65(t,J=7.3Hz,1H),6.53(d,J=8.0Hz,1H),4.60(dd,J=8.3,5.3Hz,1H),4.37(d,J=15.0Hz,1H),4.07(d,J=15.0Hz,1H),3.49-3.28(m,2H),2.13-1.81(m,3H),1.68(tt,J=11.2,8.3Hz,1H).13C NMR(126MHz,CDCl3)148.69,143.44,130.07,129.06,127.96,126.59,125.98,120.46,116.36,111.41,76.62,57.19,47.02,31.78,22.24。
example 8
Figure GDA0002582331160000082
The synthesis route of the azacyclo-quinazoline compound is as above, the preparation method is basically the same as that in example 1, except that 4-bromoaniline is adopted as aromatic amine, and the prepared azacyclo-quinazoline compound is 4- (4-bromophenyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 52%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.41(d,J=8.6Hz,2H),7.14(t,J=7.6Hz,1H),7.03(d,J=8.6Hz,2H),6.96(d,J=7.3Hz,1H),6.66(t,J=7.3Hz,1H),6.53(d,J=8.0Hz,1H),4.61(dd,J=8.2,5.4Hz,1H),4.37(d,J=15.0Hz,1H),4.08(d,J=15.0Hz,1H),3.54-3.38(m,1H),3.38-3.29(m,1H),2.11-1.88(m,3H),1.69(ddd,J=20.0,11.3,8.4Hz,1H)。13C NMR(126MHz,CDCl3)148.98,143.38,132.03,127.98,126.89,125.98,120.34,117.91,116.44,111.46,76.56,57.05,47.01,31.70,22.21。
example 9
Figure GDA0002582331160000091
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 1, except that 4-iodoaniline is adopted as aromatic amine, and the prepared azacyclo-quinazoline compound is 4- (4-iodophenyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 43%, and the product is white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.60(d,J=8.6Hz,2H),7.14(t,J=7.6Hz,1H),6.93(dd,J=28.0,8.0Hz,3H),6.66(t,J=7.3Hz,1H),6.53(d,J=8.0Hz,1H),4.61(dd,J=8.3,5.3Hz,1H),4.37(d,J=15.0Hz,1H),4.09(d,J=15.0Hz,1H),3.49-3.28(m,2H),2.14-2.03(m,1H),2.02-1.84(m,2H),1.70(tt,J=11.1,8.4Hz,1H)。13C NMR(126MHz,CDCl3)149.89,143.47,137.98,127.96,127.13,125.94,120.47,116.43,111.44,88.56,76.38,56.95,46.97,31.74,22.21。
example 10
Figure GDA0002582331160000092
A synthetic method of an azacyclo-quinazoline compound, which has the same synthetic route as that of the azacyclo-quinazoline compound in example 1, except that 4-aminobenzonitrile is used as aromatic amine, and the prepared azacyclo-quinazoline compound is 4- (4-cyanophenyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 49%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.53(d,J=8.8Hz,2H),7.20(t,J=7.4Hz,1H),7.02(dd,J=17.1,8.1Hz,3H),6.77(t,J=7.4Hz,1H),6.64(d,J=8.0Hz,1H),4.58(dd,J=8.3,5.5Hz,1H),4.46(d,J=14.7Hz,1H),4.29(d,J=14.7Hz,1H),3.44(td,J=8.3,6.4Hz,1H),3.33(td,J=8.8,5.3Hz,1H),2.37(tdd,J=8.4,5.5,3.3Hz,1H),2.14-1.92(m,2H),1.77(ddd,J=18.0,12.2,9.1Hz,1H)。13C NMR(126MHz,CDCl3)152.86,144.28,133.13,128.25,125.69,122.16,120.08,119.73,118.09,112.23,103.30,75.02,52.64,46.16,31.29,21.52。
example 11
Figure GDA0002582331160000101
The synthesis route of the azacyclo-quinazoline compound is as above, the preparation method is basically the same as that in example 1, except that 4-nitroaniline is adopted as aromatic amine, and the prepared azacyclo-quinazoline compound is 4- (4-nitrophenyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 43%, and the yellow oily liquid is obtained.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)8.18-8.11(m,2H),7.24(t,J=7.5Hz,1H),7.10(d,J=7.3Hz,1H),6.93-6.87(m,2H),6.83(t,J=7.3Hz,1H),6.71(d,J=7.9Hz,1H),4.59-4.49(m,2H),4.36(d,J=14.3Hz,1H),3.51(td,J=8.7,4.8Hz,1H),3.29(td,J=8.9,6.6Hz,1H),2.59-2.46(m,1H),2.17-1.95(m,2H),1.82(ddt,J=12.3,10.0,8.2Hz,1H)。13C NMR(126MHz,CDCl3)153.74,144.60,139.39,128.39,125.59,125.47,123.36,118.98,116.16,112.57,74.53,50.45,45.61,31.16,21.10。
example 12
Figure GDA0002582331160000102
A synthetic method of an azacyclo-quinazoline compound, which has the synthetic route as above and is prepared basically as in example 1, except that the aromatic amine used is 3, 4-dimethoxyaniline, and the prepared azacyclo-quinazoline compound is 4- (3, 4-dimethoxyphenyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 41%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.13(t,J=7.5Hz,1H),6.96(d,J=7.2Hz,1H),6.87-6.69(m,3H),6.64(t,J=7.3Hz,1H),6.52(d,J=8.0Hz,1H),4.59(dd,J=7.9,5.1Hz,1H),4.37(d,J=14.8Hz,1H),4.04(d,J=14.8Hz,1H),3.85(d,J=22.8Hz,6H),3.57-3.29(m,2H),2.12-1.81(m,3H),1.71(dt,J=19.4,8.4Hz,1H)。13C NMR(126MHz,CDCl3)148.93,146.70,143.22,127.83,126.05,120.59,116.67,116.02,111.20,111.05,110.22,57.71,55.96,55.82,47.16,31.98,22.32。
example 13
Figure GDA0002582331160000111
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 1, except that 3-chloroaniline is used as aromatic amine, and the prepared azacyclo-quinazoline compound is 4- (3-chlorophenyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 74%, and the product is white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.22(dd,J=14.3,6.3Hz,1H),7.18-7.11(m,2H),7.09(d,J=7.9Hz,1H),7.04(d,J=8.0Hz,1H),6.96(d,J=7.3Hz,1H),6.67(t,J=7.4Hz,1H),6.54(d,J=8.0Hz,1H),4.60(dd,J=8.3,5.3Hz,1H),4.35(d,J=14.9Hz,1H),4.12(d,J=14.9Hz,1H),3.52–3.30(m,2H),2.11(ddd,J=12.2,7.3,2.3Hz,1H),2.05-1.86(m,2H),1.72(tt,J=11.2,8.3Hz,1H)。13C NMR(126MHz,CDCl3)151.51,143.36,134.33,129.87,127.92,125.89,124.73,124.49,123.05,120.50,116.44,111.48,76.34,56.85,46.99,31.79,22.16。
example 14
Figure GDA0002582331160000121
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 1, except that 4-trifluoromethylaniline is adopted as aromatic amine, and the prepared azacyclo-quinazoline compound is 4- (4-trifluoromethylphenyl) -1,2,3,3a,4, 5-hexahydropyrrolo [1,2-a ] quinazoline, the yield is 76%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.53(d,J=8.5Hz,2H),7.16(d,J=8.4Hz,3H),6.99(d,J=7.3Hz,1H),6.70(t,J=7.4Hz,1H),6.57(d,J=8.0Hz,1H),4.65(dd,J=8.3,5.4Hz,1H),4.42(d,J=15.0Hz,1H),4.21(d,J=15.0Hz,1H),3.48-3.32(m,2H),2.22(tdd,J=7.7,5.5,2.7Hz,1H),2.08-1.87(m,2H),1.74(ddd,J=18.9,12.0,8.6Hz,1H)。13C NMR(126MHz,CDCl3)153.01,143.78,128.07,126.14,126.05,125.86,123.24,120.93,116.99,111.73,75.88,55.69,46.75,31.62,22.01。
example 15
A synthetic method of an azacyclo-quinazoline compound comprises the following synthetic route:
Figure GDA0002582331160000122
the method specifically comprises the following steps:
1) taking a 10mL test tube with a plug, adding 0.4mmol of 2- (1-azepanyl) benzaldehyde, 0.2mmol of aniline, 15mg of porcine gastric mucosa protease and 2mL of 50% methanol aqueous solution;
2) putting the reaction bottle in the step 1) into a constant-temperature oil bath at 55 ℃, and reacting for 36 hours under magnetic stirring to obtain a crude product;
3) and (3) carrying out column chromatography separation on the crude product obtained in the step 2), wherein dichloromethane and n-hexane are adopted as eluent in a volume ratio of 1:1, and drying for 4h at 40 ℃ to prepare the azacyclo-quinazoline compound.
The prepared azacyclo-quinazoline compound is 6-phenyl-5, 6,6a,7,8,9,10, 11-octahydro-azacyclo [1,2-a ] quinazoline, the yield is 84%, and the compound is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.24-7.20(m,2H),7.09(t,J=7.4Hz,1H),7.00(d,J=7.3Hz,1H),6.95(d,J=7.9Hz,2H),6.83(t,J=7.3Hz,1H),6.64-6.55(m,2H),4.88(dd,J=9.9,4.2Hz,1H),4.58(d,J=16.1Hz,1H),4.38(d,J=16.1Hz,1H),3.88(ddd,J=15.0,6.3,3.2Hz,1H),3.28-3.18(m,1H),2.18-2.09(m,1H),1.97-1.84(m,2H),1.68-1.58(m,3H),1.48(ddd,J=17.2,9.6,4.0Hz,1H),1.35(ddd,J=13.6,8.8,4.5Hz,1H)。13C NMR(126MHz,CDCl3)149.75,142.61,129.26,129.17,127.75,126.53,117.82,117.38,115.56,110.05,75.08,47.12,46.31,32.95,26.42,26.03,24.77.
example 16
Figure GDA0002582331160000131
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that 4-methylaniline is used as aromatic amine, and the prepared azacyclo-quinazoline compound is 6- (p-tolyl) -5,6,6a,7,8,9,10, 11-octahydro-azacyclo [1,2-a ] quinazoline, the yield is 92%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.11-6.95(m,4H),6.86(d,J=8.5Hz,2H),6.64-6.53(m,2H),4.80(dd,J=10.1,4.0Hz,1H),4.56(d,J=16.2Hz,1H),4.31(d,J=16.2Hz,1H),3.85(ddd,J=15.0,6.3,3.3Hz,1H),3.27-3.13(m,1H),2.24(s,3H),2.13(dtd,J=16.2,10.8,5.4Hz,1H),1.96-1.78(m,2H),1.72-1.56(m,3H),1.54-1.41(m,1H),1.40-1.28(m,1H)。13C NMR(126MHz,CDCl3)147.70,142.67,129.71,129.53,127.73,126.55,117.93,117.85,115.48,109.97,75.74,47.11,46.54,33.14,26.37,26.13,24.80,20.56。
example 17
Figure GDA0002582331160000141
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that the aromatic amine is 3-methylaniline, and the prepared azacyclo-quinazoline compound is 6- (m-tolyl) -5,6,6a,7,8,9,10, 11-octahydro-azacyclo [1,2-a ] quinazoline, the yield is 89%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.14-7.04(m,2H),7.00(d,J=7.2Hz,1H),6.75(d,J=8.5Hz,2H),6.68-6.54(m,3H),4.87(dd,J=9.9,4.2Hz,1H),4.56(d,J=16.1Hz,1H),4.37(d,J=16.1Hz,1H),3.88(ddd,J=15.0,6.3,3.1Hz,1H),3.29-3.19(m,1H),2.30(s,3H),2.19-2.10(m,1H),1.94-1.81(m,2H),1.70-1.58(m,3H),1.53-1.44(m,1H),1.35(ddd,J=18.6,9.2,4.2Hz,1H)。13C NMR(126MHz,CDCl3)149.68,142.60,138.81,128.99,127.71,126.54,120.79,118.08,117.92,115.55,114.31,110.07,75.07,47.12,46.27,32.73,26.43,26.03,24.76,21.90。
example 18
Figure GDA0002582331160000142
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that 4-methoxyaniline is adopted as aromatic amine, and the prepared azacyclo-quinazoline compound is 6- (4-methoxyphenyl) -5,6,6a,7,8,9,10, 11-octahydro-azacyclo [1,2-a ] quinazoline, the yield is 95%, and the compound is white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.08(t,J=7.4Hz,1H),6.94(dd,J=24.2,8.1Hz,3H),6.82-6.71(m,2H),6.65-6.52(m,2H),4.72-4.53(m,2H),4.23(d,J=16.3Hz,1H),3.88-3.76(m,1H),3.72(s,3H),3.16(ddd,J=15.4,10.2,5.6Hz,1H),2.16-2.05(m,1H),1.95(d,J=6.1Hz,1H),1.86(dtd,J=13.5,10.1,3.6Hz,1H),1.74-1.54(m,3H),1.53-1.41(m,1H),1.34(dtd,J=14.1,9.8,4.4Hz,1H)。13C NMR(126MHz,CDCl3)154.07,144.36,142.81,127.73,126.49,120.30,117.83,115.44,114.35,109.87,76.79,55.51,47.25,47.02,33.87,26.35,26.21,24.79。
example 19
Figure GDA0002582331160000151
A synthetic method of an azacycloquinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that 4-trifluoromethylaniline is used as aromatic amine, and the prepared azacycloquinazoline compound is 6- (4-trifluoromethylphenyl) -5,6,6a,7,8,9,10, 11-octahydroazepino [1,2-a ] quinazoline, the yield is 82%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.47(d,J=8.7Hz,2H),7.11(t,J=7.8Hz,1H),7.03(d,J=7.5Hz,1H),6.94(d,J=8.7Hz,2H),6.69-6.60(m,2H),4.96(dd,J=9.3,5.0Hz,1H),4.51(dd,J=45.7,16.0Hz,2H),3.91(ddd,J=15.1,6.6,3.0Hz,1H),3.31-3.19(m,1H),2.17(ddt,J=20.3,10.4,6.2Hz,1H),1.91-1.83(m,2H),1.71-1.62(m,3H),1.54-1.47(m,1H),1.39-1.33(m,1H)。13C NMR(126MHz,CDCl3)151.50,142.35,128.03,126.70,126.59,126.50,125.82,117.45,116.13,115.34,110.50,73.78,47.31,45.90,32.35,26.59,25.82,24.67。
example 20
Figure GDA0002582331160000152
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that 4-aminobenzonitrile is adopted as aromatic amine, and the prepared azacyclo-quinazoline compound is 6- (4-cyanophenyl) -5,6,6a,7,8,9,10, 11-octahydro azacyclo [1,2-a ] quinazoline, the yield is 83%, and the compound is white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.50(d,J=8.9Hz,2H),7.13(t,J=7.5Hz,1H),7.03(d,J=7.3Hz,1H),6.87(d,J=8.9Hz,2H),6.73-6.61(m,2H),5.07-4.93(m,1H),4.57-4.42(m,2H),3.92(ddd,J=15.1,6.6,2.7Hz,1H),3.35–3.21(m,1H),2.25-2.12(m,1H),1.86(dd,J=12.7,6.9Hz,2H),1.76-1.56(m,3H),1.56-1.45(m,1H),1.45-1.33(m,1H)。13C NMR(126MHz,CDCl3)151.29,142.23,133.64,128.17,126.58,120.14,117.40,116.56,114.55,110.86,100.23,72.77,47.51,45.52,31.82,26.85,25.63,24.61。
example 21
Figure GDA0002582331160000161
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that 4-chloroaniline is used as aromatic amine, and the prepared azacyclo-quinazoline compound is 6- (4-chlorophenyl) -5,6,6a,7,8,9,10, 11-octahydro-azacyclo [1,2-a ] quinazoline, the yield is 85%, and the compound is white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.22-7.14(m,2H),7.09(t,J=7.5Hz,1H),6.99(d,J=7.3Hz,1H),6.90-6.83(m,2H),6.66-6.56(m,2H),4.79(dd,J=10.0,4.2Hz,1H),4.56(d,J=16.2Hz,1H),4.31(d,J=16.2Hz,1H),3.87(ddd,J=15.0,6.3,3.3Hz,1H),3.25-3.14(m,1H),2.20-2.09(m,1H),1.96-1.81(m,2H),1.67(dddd,J=27.8,13.9,8.7,4.8Hz,3H),1.54-1.43(m,1H),1.40-1.30(m,1H)。13C NMR(126MHz,CDCl3)148.45,142.48,129.04,127.91,126.54,124.81,118.77,117.41,115.78,110.16,75.25,47.12,46.50,33.15,26.37,26.01,24.72。
example 22
Figure GDA0002582331160000162
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that the aromatic amine is 2-methylaniline, and the prepared azacyclo-quinazoline compound is 6- (m-tolyl) -5,6,6a,7,8,9,10, 11-octahydro-azacyclo [1,2-a ] quinazoline, the yield is 90%, and the product is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.08(d,J=7.2Hz,1H),7.03(t,J=7.7Hz,1H),6.93(dd,J=10.8,4.3Hz,1H),6.85(dd,J=13.6,6.9Hz,3H),6.52(t,J=7.1Hz,2H),4.65(d,J=16.9Hz,1H),4.16(dd,J=10.1,4.3Hz,1H),3.88(d,J=16.9Hz,1H),3.09-2.86(m,1H),2.26(s,3H),2.11-1.85(m,3H),1.64-1.24(m,6H)。13C NMR(126MHz,CDCl3)151.34,143.27,132.78,130.86,127.68,126.71,126.17,123.41,121.79,118.35,115.25,109.57,76.95,47.77,46.93,35.43,26.49,26.17,24.87,18.47。
example 23
Figure GDA0002582331160000171
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that the aromatic amine is 3-chloroaniline, and the prepared azacyclo-quinazoline compound is 6- (3-chlorophenyl) -5,6,6a,7,8,9,10, 11-octahydro-azacyclo [1,2-a ] quinazoline, the yield is 82%, and the compound is white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.16-7.07(m,2H),7.00(d,J=7.4Hz,1H),6.89(t,J=2.1Hz,1H),6.82-6.77(m,2H),6.67-6.59(m,2H),4.88-4.80(m,1H),4.54(d,J=16.0Hz,1H),4.37(d,J=16.1Hz,1H),3.90(ddd,J=15.1,6.5,3.0Hz,1H),3.25(ddd,J=15.8,10.3,5.9Hz,1H),2.15(ddt,J=12.2,10.5,6.1Hz,1H),1.91-1.82(m,2H),1.71-1.60(m,3H),1.53-1.45(m,1H),1.40-1.31(m,1H)。13C NMR(126MHz,CDCl3)150.70,142.45,134.97,130.22,128.00,126.64,119.50,117.51,116.78,115.97,114.94,110.38,74.51,47.19,46.28,32.66,26.51,25.95,24.72。
example 24
Figure GDA0002582331160000181
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that 4-nitroaniline is used as aromatic amine, and the prepared azacyclo-quinazoline compound is 6- (4-nitrophenyl) -5,6,6a,7,8,9,10, 11-octahydroazepino [1,2-a ] quinazoline, the yield is 71%, and the yellow oily liquid is obtained.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)8.14(d,J=9.3Hz,2H),7.16(t,J=7.6Hz,1H),7.06(d,J=7.4Hz,1H),6.82(d,J=9.3Hz,2H),6.78–6.64(m,2H),5.09(t,J=7.3Hz,1H),4.54(q,J=15.9Hz,2H),3.94(ddd,J=15.3,6.5,2.4Hz,1H),3.38-3.23(m,1H),2.25-2.13(m,1H),1.87(dd,J=12.9,6.9Hz,2H),1.78-1.66(m,2H),1.66-1.48(m,2H),1.47-.35(m,1H)。13C NMR(126MHz,CDCl3)152.47,142.18,138.32,128.30,126.60,126.14,117.47,116.93,112.62,111.16,72.44,47.71,45.58,31.44,27.13,25.49,24.60。
example 25
Figure GDA0002582331160000182
A process for the synthesis of an azacyclo-quinazoline compound according to the above scheme, substantially as described in example 15, except that the aromatic amine used is 3, 4-dimethoxyaniline, and the azacyclo-quinazoline compound prepared is 6- (3, 4-dimethoxyphenyl) -5,6,6a,7,8,9,10, 11-octahydroazepino [1,2-a ] quinazoline, in 89% yield as a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.09(t,J=7.5Hz,1H),6.98(d,J=7.3Hz,1H),6.72(d,J=8.7Hz,1H),6.60(dd,J=17.2,8.6Hz,3H),6.49(dd,J=8.6,2.3Hz,1H),4.74-4.55(m,2H),4.24(d,J=16.0Hz,1H),3.83(t,J=13.5Hz,7H),3.19(ddd,J=15.4,10.1,5.6Hz,1H),2.12(qd,J=10.7,5.5Hz,1H),2.03-1.82(m,2H),1.77-1.56(m,3H),1.54-1.44(m,1H),1.41-1.31(m,1H)。13C NMR(126MHz,CDCl3)149.27,144.88,143.77,142.67,127.78,126.43,117.75,115.50,111.75,110.43,109.88,104.59,76.88,56.16,55.85,47.49,46.99,33.89,26.31,26.20,24.76。
example 26
Figure GDA0002582331160000191
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that 4-bromoaniline is adopted as aromatic amine, and the prepared azacyclo-quinazoline compound is 6- (4-bromophenyl) -5,6,6a,7,8,9,10, 11-octahydro azacyclo [1,2-a ] quinazoline, the yield is 88%, and the compound is white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.34-7.28(m,2H),7.10(t,J=7.4Hz,1H),6.99(d,J=7.7Hz,1H),6.85-6.78(m,2H),6.67-6.55(m,2H),4.80(dd,J=10.0,4.2Hz,1H),4.55(d,J=16.2Hz,1H),4.32(d,J=16.2Hz,1H),3.87(ddd,J=15.0,6.4,3.2Hz,1H),3.22(ddd,J=15.6,10.2,5.8Hz,1H),2.24-2.08(m,1H),1.96-1.80(m,2H),1.74-1.60(m,3H),1.54-1.44(m,1H),1.41-1.30(m,1H)。13C NMR(126MHz,CDCl3)148.86,142.49,132.00,127.98,126.60,119.07,117.44,115.85,112.08,110.24,75.04,47.16,46.41,33.08,26.42,26.04,24.75。
example 27
Figure GDA0002582331160000192
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that 4-iodoaniline is adopted as aromatic amine, and the prepared azacyclo-quinazoline compound is 6- (4-iodophenyl) -5,6,6a,7,8,9,10, 11-octahydro azacyclo [1,2-a ] quinazoline, the yield is 93%, and the compound is white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.48(d,J=8.6Hz,2H),7.09(t,J=7.7Hz,1H),6.99(d,J=7.3Hz,1H),6.77-6.53(m,4H),4.81(dd,J=9.9,4.1Hz,1H),4.53(d,J=16.1Hz,1H),4.32(d,J=16.1Hz,1H),3.87(ddd,J=14.8,6.2,3.0Hz,1H),3.34-3.05(m,1H),2.23-2.08(m,1H),1.96-1.78(m,2H),1.77-1.58(m,3H),1.48(ddd,J=18.4,11.9,3.8Hz,1H),1.41-1.29(m,1H)。13C NMR(126MHz,CDCl3)149.35,142.41,137.88,127.94,126.56,119.37,117.40,115.83,110.22,81.76,74.76,47.16,46.18,32.92,26.40,25.97,24.71。
example 28
Figure GDA0002582331160000201
A synthetic method of an azacyclo-quinazoline compound, the synthetic route is as above, the preparation method is basically the same as that in example 15, except that the aromatic amine is 1-naphthylamine, and the prepared azacyclo-quinazoline compound is 6- (1-naphthyl) -5,6,6a,7,8,9,10, 11-octahydroazepino [1,2-a ] quinazoline, the yield is 78%, and the product is a white solid.
The nuclear magnetic characterization data are:13C NMR(126MHz,CDCl3)149.11,142.97,134.81,129.56,128.60,127.81,126.34,126.18,125.79,125.65,123.85,123.76,118.26,117.55,115.40,109.71,77.90,60.58,48.70,46.90,26.42,26.15,24.86,17.88。
example 29
A synthetic method of [1,2-a ] quinazoline compounds comprises the following synthetic route:
Figure GDA0002582331160000202
the method specifically comprises the following steps:
1) taking a 10mL test tube with a stopper, and adding 0.4mmol of 2- (3, 4-dihydro-2 (1H) isoquinolyl) benzaldehyde, 0.2mmol of aniline, 25mg of porcine gastric mucosa protease and 2mL of methanol aqueous solution;
2) putting the reaction bottle in the step 1) into a constant-temperature oil bath at 60 ℃, and reacting for 48 hours under magnetic stirring to obtain a crude product;
3) and (3) carrying out column chromatography separation on the crude product obtained in the step 2), wherein dichloromethane and n-hexane are adopted as eluent in a volume ratio of 1:1, and drying for 3h at 50 ℃ to prepare the azacyclo-quinazoline compound.
The prepared azacyclo-quinazoline compound is 5-phenyl-4 b,5,12,13 tetrahydro-6H-isoquinolino [2,1-a ]]Quinazoline, yield 88%, white solid, nuclear magnetic characterization data:1H NMR(500MHz,CDCl3)7.60(d,J=7.4Hz,1H),7.32-7.11(m,6H),7.09(t,J=7.6Hz,1H),7.02(d,J=7.2Hz,1H),6.95(d,J=8.2Hz,1H),6.88(t,J=6.6Hz,2H),6.66(t,J=7.3Hz,1H),6.03(s,1H),4.40(d,J=16.6Hz,1H),4.32(d,J=16.6Hz,1H),4.22(dd,J=14.4,5.2Hz,1H),3.45(td,J=14.2,3.8Hz,1H),3.22-3.02(m,1H),2.62-2.42(m,1H)。13C NMR(126MHz,CDCl3)150.86,143.84,137.40,136.66,129.32,129.03,127.70,127.59,126.96,126.43,125.99,122.15,120.81,118.54,118.14,113.72,73.90,46.52,45.33,24.96。
example 30
Figure GDA0002582331160000211
A process for the synthesis of an azacycloquinazoline compound, which comprises the steps of providing the compound in the above-mentioned order, and reacting the compound with an aromatic amine, wherein the aromatic amine is 4-methylaniline, and the azacycloquinazoline compound is 5- (4-methylphenyl) -4b,5,12, 13-tetrahydro-6H-isoquinolino [2,1-a ] quinazoline, and the yield is 93%, and the compound is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.72(d,J=7.3Hz,1H),7.34-7.23(m,2H),7.20-7.06(m,6H),7.02(d,J=8.1Hz,1H),6.96(d,J=7.0Hz,1H),6.73(t,J=7.1Hz,1H),6.05(s,1H),4.47(d,J=16.7Hz,1H),4.31(dd,J=26.7,11.2Hz,2H),3.51(t,J=11.9Hz,1H),3.19(t,J=11.8Hz,1H),2.59(d,J=16.3Hz,1H),2.32(s,3H)。13C NMR(126MHz,CDCl3)148.61,143.89,137.51,136.66,130.37,129.79,128.94,127.60,127.51,126.92,126.37,126.03,122.20,118.99,118.03,113.62,74.45,46.69,45.27,25.02,20.66。
example 31
Figure GDA0002582331160000221
A process for the synthesis of an azacycloquinazoline compound, which comprises the following steps, wherein the process is substantially the same as in example 29, except that the aromatic amine used is 3-methylaniline, and the azacycloquinazoline compound is prepared as 5- (3-methylphenyl) -4b,5,12, 13-tetrahydro-6H-isoquinolino [2,1-a ] quinazoline, in a yield of 86% as a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.58(d,J=7.4Hz,1H),7.23-7.05(m,4H),7.02(d,J=7.3Hz,1H),6.99-6.91(m,3H),6.88(d,J=7.3Hz,1H),6.77-6.58(m,2H),6.04(s,1H),4.39(d,J=16.6Hz,1H),4.30(d,J=16.7Hz,1H),4.23(dd,J=14.5,5.3Hz,1H),3.54-3.38(m,1H),3.20-3.03(m,1H),2.51(dd,J=16.6,3.4Hz,1H),2.29(s,3H)。13CNMR(126MHz,CDCl3)150.87,143.81,139.03,137.51,136.67,129.18,129.03,127.65,127.57,126.94,126.41,125.97,122.23,121.63,119.13,118.14,115.27,113.74,73.86,46.28,45.39,24.88,21.92。
example 32
Figure GDA0002582331160000222
A process for the synthesis of an azacycloquinazoline compound according to the general formula given in example 29, which comprises the steps of providing the aromatic amine 4-fluoroaniline, and providing an azacycloquinazoline compound which is 5- (4-fluorophenyl) -4b,5,12, 13-tetrahydro-6H-isoquinolino [2,1-a ] quinazoline in a yield of 81% as a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.65(d,J=7.6Hz,1H),7.27-7.14(m,2H),7.14-7.05(m,3H),7.03(d,J=7.4Hz,1H),6.99-6.82(m,4H),6.67(t,J=7.3Hz,1H),5.87(s,1H),4.40(d,J=16.8Hz,1H),4.27-4.15(m,2H),3.52-3.31(m,1H),3.19-2.97(m,1H),2.52(dd,J=16.5,3.2Hz,1H)。13C NMR(126MHz,CDCl3)158.84,156.93,147.29,143.94,137.11,136.63,128.97,127.79,126.99,126.41,126.08,121.88,121.18,121.12,118.23,115.73,115.56,113.65,74.78,47.67,45.13,25.19。
example 33
Figure GDA0002582331160000231
A process for the synthesis of an azacycloquinazoline compound, which comprises the steps of providing the compound in the above-mentioned order, and reacting the compound with an aromatic amine, wherein the aromatic amine is 4-chloroaniline, and the azacycloquinazoline compound is 5- (4-chlorophenyl) -4b,5,12, 13-tetrahydro-6H-isoquinolino [2,1-a ] quinazoline, and the yield is 67% as a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.56(d,J=7.4Hz,1H),7.26-7.14(m,4H),7.14-7.00(m,4H),6.96(d,J=8.3Hz,1H),6.88(d,J=7.3Hz,1H),6.68(t,J=7.3Hz,1H),5.96(s,1H),4.40(d,J=16.6Hz,1H),4.25(dt,J=20.5,7.4Hz,2H),3.51-3.35(m,1H),3.17-3.02(m,1H),2.54(dd,J=16.6,3.5Hz,1H)。13C NMR(126MHz,CDCl3)149.39,143.70,136.87,136.57,129.12,129.04,127.84,127.68,126.97,126.42,125.88,125.71,121.72,120.06,118.31,113.79,73.95,46.98,45.28,24.99。
example 34
Figure GDA0002582331160000232
A process for the synthesis of an azacycloquinazoline compound, which comprises the steps of providing the compound in the above-mentioned order, and reacting the compound with an aromatic amine, wherein the aromatic amine is 4-trifluoromethylaniline, and the azacycloquinazoline compound is 5- (4-trifluoromethylphenyl) -4b,5,12, 13-tetrahydro-6H-isoquinolino [2,1-a ] quinazoline, and the yield is 71%, and the compound is a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.54-7.39(m,3H),7.25-7.08(m,5H),7.07-7.01(m,1H),6.98(d,J=8.2Hz,1H),6.90(d,J=7.3Hz,1H),6.69(t,J=7.3Hz,1H),6.12(s,1H),4.50-4.33(m,2H),4.26(dd,J=14.5,5.3Hz,1H),3.50(td,J=14.3,4.0Hz,1H),3.22-3.03(m,1H),2.56(dd,J=16.7,3.3Hz,1H)。13C NMR(126MHz,CDCl3)153.04,143.46,136.52,136.48,129.21,127.99,127.83,127.00,126.66,126.63,126.50,125.65,121.56,118.56,116.87,114.01,72.82,46.25,45.48,24.75。
example 35
Figure GDA0002582331160000241
A process for the synthesis of an azacycloquinazoline compound, which comprises the steps of providing the compound in the above-mentioned manner, and substantially the same preparation as in example 29, except that 4-aminobenzonitrile is used as the aromatic amine, and 5- (4-aminophenyl) -4b,5,12, 13-tetrahydro-6H-isoquinolino [2,1-a ] quinazoline is prepared in a yield of 43% as a white solid.
The nuclear magnetic characterization data are:1H NMR(500MHz,CDCl3)7.52(d,J=8.6Hz,2H),7.31(d,J=6.4Hz,1H),7.12(ddd,J=36.9,18.5,9.3Hz,6H),7.01(d,J=8.2Hz,1H),6.92(d,J=7.3Hz,1H),6.72(t,J=7.3Hz,1H),6.17(s,1H),4.52-4.36(m,2H),4.29(dd,J=14.4,5.3Hz,1H),3.61-3.46(m,1H),3.23-3.07(m,1H),2.67-2.51(m,1H)。13C NMR(126MHz,CDCl3)153.29,143.16,136.36,135.85,133.72,129.32,128.10,127.96,126.96,126.48,125.42,121.20,119.90,118.77,116.32,114.15,101.74,71.96,45.92,45.57,24.55。
the substrate has a great influence on the yield of the azacyclo-quinazoline compound synthesized by the method, and the influence on the yield is shown in table 1.
TABLE 1 influence of the substrates on the yield of the azacyclo-quinazoline compounds synthesized according to the invention
Figure GDA0002582331160000242
Figure GDA0002582331160000251
Figure GDA0002582331160000261
Comparative example
The reaction process is as follows:
the reaction was carried out at 50 ℃ in 2mL of a solvent using 0.2mmol of 2- (1-pyrrolidinyl) benzaldehyde and 0.22mmol of aniline, and the reaction was catalyzed by 15mg of porcine gastric mucosa protease under different conditions as shown in Table 2 below, and it can be seen that the yield was the best when methanol was mixed with water at 1: 1.
TABLE 2 comparison of reaction yields under different solvent conditions
Figure GDA0002582331160000262
While the present invention has been described in detail with reference to the preferred embodiments, it should be understood that the above description should not be taken as limiting the invention. Various modifications and alterations to this invention will become apparent to those skilled in the art upon reading the foregoing description. Accordingly, the scope of the invention should be determined from the following claims.

Claims (7)

1. A method for synthesizing an azacyclo-quinazoline compound is characterized by comprising the following steps:
Figure FDA0002582331150000011
placing benzaldehyde with a structure shown in a formula A and aromatic amine with a structure shown in a formula B in a methanol water solution or a methanol solution, wherein the molar ratio of the benzaldehyde to the aromatic amine is more than or equal to 2: 1, stirring at a constant temperature of 55-65 ℃ under the catalytic action of porcine gastric mucosal protease, and reacting to obtain an azacyclo-quinazoline compound with a structure shown in a formula C;
wherein R is1And R2Are linked to form a nitrogen heterocycle R1And R2is-CH2-(CH2)m-CH2-, m is 1 to 6; or
Figure FDA0002582331150000013
n is 0-4, and D is a carbocyclic ring or a heterocyclic ring;
the aromatic amine has a structure shown as formula E or F:
Figure FDA0002582331150000012
wherein R is3And R4Each independently is H, or an electron donating substituent, or an electron withdrawing substituent; g is a carbocyclic or heterocyclic ring;
the electron-donating substituent is selected from any one of methyl, ethyl, methoxy and ethoxy; the electron-withdrawing substituent is selected from any one of halogen, trifluoromethyl, nitro and cyano.
2. The method for synthesizing the azacyclo-quinazoline compound according to claim 1, wherein the volume ratio of methanol to water in the methanol aqueous solution is 1: 2-2: 1.
3. the method for synthesizing the azacyclo-quinazoline compound according to claim 1, wherein the stirring speed is 150-250 rpm.
4. The method for synthesizing the azacyclo-quinazoline compound according to claim 1, wherein the reaction time is not less than 36 h.
5. The method for synthesizing the azacyclo-quinazoline compound as claimed in claim 1, wherein the mass molar ratio of the porcine gastric mucosal protease to the aromatic amine is 75mg:1mmol to 150mg:1 mmol; the volume mol ratio of the methanol water solution to the aromatic amine is 5mL:1 mmol-10 mL:1 mmol.
6. The method for synthesizing the azacyclo-quinazoline compound according to claim 1, wherein after the reaction is completed, the azacyclo-quinazoline compound is separated and purified by column chromatography.
7. The method of claim 1, wherein D is an aromatic ring.
CN201910425623.6A 2019-05-21 2019-05-21 Synthetic method of azacyclo-quinazoline compound Active CN110156789B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910425623.6A CN110156789B (en) 2019-05-21 2019-05-21 Synthetic method of azacyclo-quinazoline compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910425623.6A CN110156789B (en) 2019-05-21 2019-05-21 Synthetic method of azacyclo-quinazoline compound

Publications (2)

Publication Number Publication Date
CN110156789A CN110156789A (en) 2019-08-23
CN110156789B true CN110156789B (en) 2020-09-04

Family

ID=67631857

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910425623.6A Active CN110156789B (en) 2019-05-21 2019-05-21 Synthetic method of azacyclo-quinazoline compound

Country Status (1)

Country Link
CN (1) CN110156789B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111620824B (en) * 2020-06-24 2023-08-22 武汉理工大学 Method for synthesizing quinazoline compound by taking aromatic aldehyde as substrate
CN113373187B (en) * 2021-05-26 2023-11-10 江苏阿尔法药业股份有限公司 Nitrogen heterocyclic compound C 27 H 30 FNO 6 Is a method for enzymatic synthesis of (a)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105755066A (en) * 2016-04-07 2016-07-13 西南大学 Application and method for synthesizing dihydrothiophene compounds by porcine pepsin catalytic asymmetric thia Michael/aldol tandem reaction
CN109651375A (en) * 2018-12-27 2019-04-19 上海应用技术大学 A kind of tetrahydro quinazoline derivative and its synthetic method and application

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105755066A (en) * 2016-04-07 2016-07-13 西南大学 Application and method for synthesizing dihydrothiophene compounds by porcine pepsin catalytic asymmetric thia Michael/aldol tandem reaction
CN109651375A (en) * 2018-12-27 2019-04-19 上海应用技术大学 A kind of tetrahydro quinazoline derivative and its synthetic method and application

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Chen Zhang,等.Facile Formation of Cyclic Aminals through a Brønsted Acid-Promoted Redox Process.《J. Org. Chem.》.2008,第74卷第419-422页. *
Keiji Mori,等.Expeditious Construction of Quinazolines via Brønsted Acid-induced.《Chemistry Letters》.2009,第38卷(第6期),第524-525页. *
胃蛋白酶催化合成2,3-二氢喹唑啉-4(1H)-酮衍生物;谢宗波,等;《有机化学》;20171231;第37卷;第514-519页,尤其参见第515页左栏反应式,第515-516页第1.1-1.3节、表1、表2、表3,第517页第3.2节 *

Also Published As

Publication number Publication date
CN110156789A (en) 2019-08-23

Similar Documents

Publication Publication Date Title
Aday et al. Graphene oxide as highly effective and readily recyclable catalyst using for the one-pot synthesis of 1, 8-dioxoacridine derivatives
CN110156789B (en) Synthetic method of azacyclo-quinazoline compound
Rehák et al. Thiol-free synthesis of oseltamivir and its analogues via organocatalytic Michael additions of oxyacetaldehydes to 2-acylaminonitroalkenes
Ganesan et al. β-Naphthol in glycerol: a versatile pair for efficient and convenient synthesis of aminonaphthols, naphtho-1, 3-oxazines, and benzoxanthenes
CN106349147A (en) Synthetic method of pyrrole derivatives
CN115385916B (en) Chiral indoline pyrrole compound and synthesis method thereof
CN110204481B (en) Polysubstituted nitrogen-containing aromatic heterocyclic compound and preparation method and application thereof
Cao et al. Photocatalytic Enantioselective Hydrosulfonylation of α, β‐Unsaturated Carbonyls with Sulfonyl Chlorides
Dong et al. Silver-Catalyzed One-Pot Biarylamination of Quinones with Arylamines: Access to N-Arylamine-Functionalized p-Iminoquinone Derivatives
CN108610275A (en) A kind of synthetic method of 3- (2- vinyls) indole derivatives
CN112939883B (en) Preparation method of polysubstituted 1, 3-oxazolidine compound
CN110684043B (en) C-N axis chiral arylamine compound and preparation method thereof
Carson et al. The reaction of nitrones with cyclopropanes: a convenient preparation of tetrahydro-1, 2-oxazines
CN105254530A (en) Method for synthesizing Schiff base compound containing camphenyl
Willong et al. Eco-Friendly Synthesis of 1, 4-dihydropyridines Derivatives Using Fe3O4@ Phen@ Cu Magnetic Catalyst
Blaser et al. Ethyl 2, 4-dioxo-4-phenylbutyrate: a versatile intermediate for the large-scale preparation of enantiomerically pure α-hydroxy and α-amino acid esters
CN112694430A (en) Preparation method of 1, 5-dihydro-2H-pyrrole-2-ketone compound
CN111978194A (en) Preparation method of aryl acetamide compound
CN107089934B (en) Water-soluble organic trivalent iodine reagent sulfamic acid iodoso benzene-like compounds and synthesis
Li et al. NHC-catalyzed [3+ 3] cycloaddition of α-bromoenals with nitroketene aminals or nitroketene N, S-acetals: synthesis of nitro-containing dihydropyridin-2-ones
CN111100085A (en) Preparation method of 3-aryl-2H-benzo [ β ] [1,4] benzoxazine-2-one compound
CN106854191B (en) 2- 3- methylene -2,3-dihydrofuran synthetic methods containing chiral quaternary carbon center
JP2009263233A (en) Method for producing asymmetrically catalyzed michael reaction product, and method for producing pharmaceutical compound
CN107628979A (en) A kind of method of synthesis 2H aziridine acid amides
CN108558751B (en) Synthesis process of 3-nitroquinoline derivative

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant